Advertisement

Acute Pulmonary Embolism: Hemodynamic Aspects and Treatment

  • G. Della Rocca
  • C. Coccia
  • I. Reffo

Abstract

Pulmonary embolism (PE) is a major international health problem, with an annual estimated incidence of over 100,000 cases in France, 65,000 cases among hospitalized patients in England and Wales, and at least 60,000 new cases per year in Italy. The diagnosis is often untreated, difficult to obtain and is frequently missed [1]. Mortality in the untreated is approximately 30%, but with adequate treatment this can be reduced to 2–8%. Numerous cases go unrecognized and hence untreated, with poor outcomes. Indeed the prevalence of PE at autopsy (approximately 12–15% in hospitalized patients) has not changed over three decades [2].

Keywords

Nitric Oxide Pulmonary Embolism Pulmonary Hypertension Right Ventricular Pulmonary Arterial Pressure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    (2000) Task force on Pulmonary Embolism. European Society of Cardiology. Guidelines on diagnosis and management of acute pulmonary embolism. Eur Heat J 21:1301–1336Google Scholar
  2. 2.
    Stein PD, Henry JW (1995) Prevalence of acute pulmonary embolism among patients in a general hospital at autopsy. Chest 108:78–81CrossRefGoogle Scholar
  3. 3.
    Morpurgo M, Rustici A (1988) Lo spettro dell’embolia polmonare. Cardiologia 33:1105–1108PubMedGoogle Scholar
  4. 4.
    Morpurgo M, Schmid C (1980) Clinic-pathologic correlations in pulmonary embolism: a posteriori evaluation. Prog Res Dis 13:8–15Google Scholar
  5. 5.
    Pacouret G, Alison D, Pottier JM et al (1997) Free-floating thrombus and embolic risk in patients with angiographically confirmed proximal deep venous thrombosis: a prospective study. Arch Intern Med 157:305–308PubMedCrossRefGoogle Scholar
  6. 6.
    Barrit DW, Jordan SC (1961) Clinical features of pulmonary embolism. Lancet 1:729–739CrossRefGoogle Scholar
  7. 7.
    Goldhaber SZ, Hennekens CH, Evans D et al (1982) Factors associated with corrected antemortem major of pulmonary embolism. Am J Med 73:822–826PubMedCrossRefGoogle Scholar
  8. 8.
    Kasper W, Konstantinides S, Tiede N et al (1997) Prognostic significance of right ventricular afterload stress detected by echocardiography in patient with clinically suspected pulmonary embolism. Heart 77:346–349PubMedCentralPubMedGoogle Scholar
  9. 9.
    Ribeiro A, Lindmarker P, Jublin-Dannfelt A et al (1997) Echocardiography Doppler in pulmonary embolism: right ventricular dysfunction as a predictor of mortality. Am Heart J 134:479–487PubMedCrossRefGoogle Scholar
  10. 10.
    Konstantinides S, Geribel A, Kasper W et al (1988) Patent foramen ovale is an important predictor of adverse outcome in patients with major pulmonary embolism. Circulation 97:1946–1951CrossRefGoogle Scholar
  11. 11.
    Sasahara AA, Maclntyre KM, Cella G et al (1988) The clinical and the hemodynamic feature of pulmonary embolism. Curr Pulmonol 9:305–346Google Scholar
  12. 12.
    Kenneth E, Wood DO (2002) Review of a pathophysiologic apport to the golden hour of hemodynamically significant pulmonary embolism. Chest 121:877–905CrossRefGoogle Scholar
  13. 13.
    McIntyre KM, Sasahara AA (1974) Determinants of right ventricular function and haemodynamics after pulmonary embolism. Chest 65:534–643PubMedGoogle Scholar
  14. 14.
    Mclntyre KM, Sasahara AA (1974) Hemodynamic and ventricular responses to pulmonary embolism. Prog Cardiovasc Dis 17:175–190CrossRefGoogle Scholar
  15. 15.
    Benis CE, Serur JR, Borkenaghen D et al (1974) Influence of right ventricular filling pressure on left ventricular pressure and dimission. Circ Res 34:498–504CrossRefGoogle Scholar
  16. 16.
    Menzel T, Wagner S, Kramm T et al (2000) Pathophysiology of impaired right and left ventricular function in chronic embolic pulmonary hypertension. Chest 118:897–903PubMedCrossRefGoogle Scholar
  17. 17.
    Belenkie I, Dani R, Smith ER, Tyberg JV (1988) Ventricular interaction during experimental acute pulmonary embolism. Circulation 78:761–768PubMedCrossRefGoogle Scholar
  18. 18.
    Adam JE, Siegel BA, Goldstein et al (1992) Elevation of CK-MB following pulmonary embolism. Chest 101:1203–1236CrossRefGoogle Scholar
  19. 19.
    Ramirez-Rivera A, Gutiérrez-Fajardo P, Jerjez-Sanchez C et al (1993) Acute right myocardial infarction without significant obstructive coronary lesions secondary to massive pulmonary embolism. Chest 104:80SGoogle Scholar
  20. 20.
    Konstantinides S, Geibel A, Olschewski M et al (2002) Importance of toponins I and T in risk stratification of patients with acute pulmonary embolism. Circulation 106:1263–1268PubMedCrossRefGoogle Scholar
  21. 21.
    Manier G, Castaing Y, Guenard H (1985) Determinants of hypoxemia during the acute phase of pulmonary embolism in humans. Am Rev Respir Dis 132:332–338PubMedGoogle Scholar
  22. 22.
    Krivec B, Voga G, Zuran I et al (1997) Diagnosis and treatment of shock due to massive pulmonary embolism. Approach with transesophageal echocardiography and intrapulmonary thrombolysis. Chest 112:1310–1316Google Scholar
  23. 23.
    Palla A, Petruzzelli S, Donnamaria V et al (1995) The role of suspicion in the diagnosis of pulmonary embolism. Chest 107:21S–24SPubMedCrossRefGoogle Scholar
  24. 24.
    Kohen H, Koenig B, Mostbeck A (1987) Incidence and clinical feature of pulmonary embolism in patients with deep vein thrombosis: a prospective study. Eur J Nucl Med 13:S11–S15Google Scholar
  25. 25.
    Kakkar VV, Flanc C, Howe CT, Clarke MB (1969) Natural history of postoperative deep-vein thrombosis. Lancet 2:230–232PubMedCrossRefGoogle Scholar
  26. 26.
    Mathru M, Venus B, Smith R et al (1986) Treatment of low cardiac output complicating acute pulmonary hypertension in normovolemic goals. Crit Care Med 14:120–124PubMedGoogle Scholar
  27. 27.
    Ducas J, Prewitt RM (1987) Pathophysiology and therapy of right ventricular dysfunction due to pulmonary embolism. Cardiovasc Clin 17:191–202PubMedGoogle Scholar
  28. 28.
    Prewitt RM (1997) pharmacological hemodynamic support in massive pulmonary embolism. Chest 111:218–224CrossRefGoogle Scholar
  29. 29.
    Mercat A, Diehl JL, Meyer G et al (1999) Hemodynamic effects of fluid loading in acute massive pulmonary embolism. Crit Care Med 27:540–544PubMedGoogle Scholar
  30. 30.
    Ghignone M, Girling L, Prewitt RM (1984) Volume expansion versus nore-phinephrine in treatment of a low cardiac output complicating an acute in righr ventricular afterloads in dogs. Anesthesiology 80:132–135CrossRefGoogle Scholar
  31. 31.
    Molloy DW, Lee KY, Jones D et al (1985) Effects of noradrenaline and isoproterenol on cardio-pulmonary function in a canine model of acute pulmonary hypertension. Chest 88:432–435PubMedCrossRefGoogle Scholar
  32. 32.
    Angle MH, Molloy DW, Penner B et al (1989) The cardiopulmonary and renal hemo-dynamc effects of norephinephrine in canine pulmonary embolism. Chest 95:1333–1337PubMedCrossRefGoogle Scholar
  33. 33.
    Wolfe MW, Saad RM, Spence TH (1992) Hemodynamic effects of amrinone in a canine model of massive pulmonary embolism. Chest 102:274–278PubMedCrossRefGoogle Scholar
  34. 34.
    Hill NS, Rounds S (1983) Amrinone dilates pulmonary vessels and blunts hypoxic vasoconstriction in isolated rat lungs. Proc Soc Exp Biol Med 173:205–212PubMedCrossRefGoogle Scholar
  35. 35.
    Manier G, Castaing Y (1992) Influence of cardiac output on oxygen exchange in acute pulmonary embolism. Am Rev Respir Dis 145:130–136PubMedCrossRefGoogle Scholar
  36. 36.
    Jardin F, Genevray B, Brun-Neg D et al (1985) Dobutamine: a hemodynamic evaluation in pulmonary embolism shock. Crit Care Med 13:1009–1012PubMedGoogle Scholar
  37. 37.
    Layish DT, Tapson VF (1997) Pharmacological hemodynamic support in massive pulmonary embolism. Chest 111:218–224PubMedCrossRefGoogle Scholar
  38. 38.
    Triantafillou AN, Pohl MS, Okabayashi K et al (1995) Effect of inhaled nitric oxide and prostaglandin E1 on hemodynamic and arterial oxygénation in patients following single lung transplantation. Anesth Analg 8o:SCA 40Google Scholar
  39. 39.
    Walmrath D, Schermuly R, Pilch J et al (1997) Effect of inhaled versus intravenous vasodilators in experimental pulmonary hypertension. Eur Respir J 10:1084–1092PubMedCrossRefGoogle Scholar
  40. 40.
    Brienza A (1999) Strategies on management of pulmonary hypertension. Minerva Anestesiol 65:769–773PubMedGoogle Scholar
  41. 41.
    Capellier G, Jacques T, Balay P et al (1997) Inhaled nitric oxide in patients with pulmonary embolism. Intensive Care Med 1089–1092Google Scholar
  42. 42.
    Vizza CD, Della Rocca G, Di Roma A et al (2001) Acute hemodynamic effects of inhaled nitric oxide, dobutamine and a combination of two in patients with mild to moderate secondary pulmonary hypertension. Critical Care 5:355–361PubMedCentralPubMedCrossRefGoogle Scholar
  43. 43.
    Haraldsson A, Kieler-Jensen N, Ricksten SE et al (1996) Inhaled prostcyclin for treatment of pulmonary hypertension after cardiac surgery or heart transplantation: a pharmacodynamic study. J Cardiothorac Vasc Anesth 10:864–868PubMedCrossRefGoogle Scholar
  44. 44.
    Olschewski H, Gofrani HA, Walmarath D et al (1999) Inhaled prostcyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis. Am J Respir Crit Care Med 160:600–607PubMedGoogle Scholar
  45. 45.
    Mirza I, Nagamine J, Pearl RG (1997) Additive effects of inhaled prostacyclin and inhaled nitric oxide in reducing experimental pulmonary hypertension. Anesthesiology 87:1122CrossRefGoogle Scholar
  46. 46.
    Hill LL, Pearl RG (1999) Combined inhaled nitric oxide and inhaled prostacyclin during experimental chronic pulmonary hypertension. J Appl Physiol 86:1160–1164PubMedGoogle Scholar
  47. 47.
    Della Rocca G, Coccia C, Pompei L et al (2001) Hemodynamic and oxygenation changes of combined therapy with inhaled nitric oxide and inhaled areosolized prostacyclin. J Cardiothorac Vasc Anesth 15:224–227CrossRefGoogle Scholar
  48. 48.
    Ginsberg JS (1996) Management of venous thromboembolism. N Engl J Med 335:1816–1828PubMedCrossRefGoogle Scholar
  49. 49.
    Goldhaber SZ (1998) Pulmonary Embolism. New Engl J Med 339:93–104PubMedCrossRefGoogle Scholar
  50. 50.
    Hyers TM, Russell DH, Weg JG (1995) Antithrombotic therapy for venous throm-boembolic disease. Chest 108:335S-351SGoogle Scholar
  51. 51.
    Shulman S, Rhedin AS, Lindmarker P et al (1995) A comparison of six weeks with six months of oral anticoagulation therapy after a first episode of venous thrrom-boembolism. N Eng J Med 332:1661–1665CrossRefGoogle Scholar
  52. 52.
    Ahearn GS, Hadjiadis D, Govert JA et al (2002) Massive pulmonary embolism during pregnancy succesfully treated with recombinant tissue plasminogen activator. A case report and review of treatment options. Arch Int Med 162:1221–1227Google Scholar
  53. 53.
    Hamel E, Pacouret G, Vinentelli D et al (2001) Thrombolysis or heparin therapy in massive pulmoanry embolism with right ventricular dilation. Chest 120:120–125PubMedCrossRefGoogle Scholar
  54. 54.
    Konstantinides S, Geibel A, Olschewski M et al (1997) Association between throim-bolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism. Circulation 96:882–888PubMedCrossRefGoogle Scholar
  55. 55.
    Arcaoy Sm, Kreit JW (1999) Thrombolytic therapty of pulmonary embolism. Chest 115:1695–1707CrossRefGoogle Scholar
  56. 56.
    Sors H, Pacouret G, Azarian R, Meyer G et al (1994) Hemodynamic effects of bolus vs 2-h infusion of alteplase in acute massive pulmonary embolism. A randomized controlled multicenter trial. Chest 106:712–717Google Scholar
  57. 57.
    Wood KE (2002) Major pulmonary embolism. Review of a patophysiologic approach to the Golden Hour of hemodynamically significant pulmoanry embolism. Chest 121:877–905Google Scholar
  58. 58.
    Girard P, Stern JB, Parent F (2002) Medical literature and the Vena Cava filters. Chest 122:963–967PubMedCrossRefGoogle Scholar
  59. 59.
    (1999) Participants in the Vena Cava Filter Consensus Conference. Recommended reporting standards foe vena cavai filter placement and patients follow-up. J Vasc Surg 30:573–579Google Scholar

Copyright information

© Springer-Verlag Italia 2004

Authors and Affiliations

  • G. Della Rocca
  • C. Coccia
  • I. Reffo

There are no affiliations available

Personalised recommendations